| Income Statement |
| Operating Expenses | 1.17M |
|
| Research and Development Expense | 224.00K |
| Selling, General and Administrative Expense | 946.00K |
| Operating Income | -1.17M |
| Net Income | -1.07M |
| Net Income Common Stock | -1.07M |
| Net Income Common Stock (USD) | -1.07M |
| Consolidated Income | -1.07M |
| Earnings per Basic Share | -0.16 |
| Earnings per Basic Share (USD) | -0.16 |
| Earnings per Diluted Share | -0.16 |
| Earning Before Interest & Taxes (EBIT) | -1.07M |
| Earning Before Interest & Taxes (USD) | -1.07M |
| Weighted Average Shares | 6.73M |
| Weighted Average Shares Diluted | 6.73M |
| Balance Sheet |
| Cash and Equivalents | 15.15M |
| Cash and Equivalents (USD) | 15.15M |
| Trade and Non-Trade Receivables | 217.00K |
| Current Assets | 15.61M |
| Total Assets | 15.61M |
| Current Liabilities | 7.92M |
| Total Liabilities | 8.07M |
| Accumulated Retained Earnings (Deficit) | -400.67M |
| Shareholders Equity | 7.55M |
| Shareholders Equity (USD) | 7.55M |
| Deferred Revenue | 150.00K |
| Liabilities Non-Current | 150.00K |
| Trade and Non-Trade Payables | 7.92M |
| Cash Flow |
| Net Cash Flow from Financing | -141.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.11M |
| Issuance (Purchase) of Equity Shares | -141.00K |
| Net Cash Flow from Operations | -967.00K |
| Share Based Compensation | 21.00K |